Experimental Hematology
Volume 36, Issue 9 , Pages 1078-1083 , September 2008

Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia

  • Vivek Subbiah

      Affiliations

    • Experimental Hematology and Hematopoiesis Section, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Department of Internal Medicine/Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA
    • ,
  • Aaron D. Viny

      Affiliations

    • Experimental Hematology and Hematopoiesis Section, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA
    • ,
  • Steven Rosenblatt

      Affiliations

    • Department of General Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Brad Pohlman

      Affiliations

    • Experimental Hematology and Hematopoiesis Section, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Alan Lichtin

      Affiliations

    • Experimental Hematology and Hematopoiesis Section, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • ,
  • Jaroslaw P. Maciejewski

      Affiliations

    • Experimental Hematology and Hematopoiesis Section, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA
    • Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA
    • Corresponding Author InformationOffprint requests to: Jaroslaw P. Maciejewski, M.D., Ph.D., Experimental Hematology and Hematopoiesis Section, Taussig Cancer Center R/40, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Received 17 January 2008 ,Revised 1 April 2008 ,Accepted 8 April 2008.

References 

  1. Kanchan K, Loughran TP. Antigen-driven clonal T cell expansion in disorders of hematopoiesis. Leuk Res. 2003;27:291–292
  2. Lamy T, Loughran TP. Clinical features of large granular lymphocyte leukemia. Semin Hematol. 2003;40:185–195
  3. Wlodarski MW, Schade AE, Maciejewski JP. T-large granular lymphocyte leukemia: current molecular concepts. Hematology. 2006;11:245–256
  4. Lazaro E, Caubet O, Menard F, Pellegrin JL, Viallard JF. Large granular lymphocyte leukemia. Presse Med. 2007;36:1694–1700
  5. Dhodapkar MV, Li CY, Lust JA, Tefferi A, Phyliky RL. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?. Blood. 1994;84:1620–1627
  6. Sabnani I, Tsang P. Are clonal T-cell large granular lymphocytes to blame for unexplained haematological abnormalities?. Br J Haematol. 2007;136:30–37
  7. Semenzato G, Zambello R, Starkebaum G, Oshimi K, Loughran TP. The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis. Blood. 1997;89:256–260
  8. Lima M, Almeida J, Santos AH, et al. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease. Am J Pathol. 2001;159:186–11868
  9. Lamy T, Loughran TP. Current concepts: large granular lymphocyte leukemia. Blood Rev. 1999;13:230–240
  10. Melenhorst JJ, Eniafe R, Follmann D, et al. T-cell large granular lymphocyte leukemia is characterized by massive TCRBV-restricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57. Hematol J. 2003;4:18–25
  11. Alekshun TJ, Sokol L. Diseases of large granular lymphocytes. Cancer Control. 2007;14:141–150
  12. O'Malley DP. T-cell large granular leukemia and related proliferations. Am J Clin Pathol. 2007;127:850–859
  13. Loughran TP, Starkebaum G, Clark E, Wallace P, Kadin ME. Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol. 1987;67:135–140
  14. Lanzi S, Lancini GP, Piardi T, et al. Splenectomy in immune thrombocytopenia and other hematological diseases. G Chir. 1999;20:479–486
  15. Font J, Jimenez S, Cervera R, et al. Splenectomy for refractory Evans' syndrome associated with antiphospholipid antibodies: report of two cases. Ann Rheum Dis. 2000;59:920–923
  16. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995–1008
  17. Bromberg ME. Immune thrombocytopenic purpura—the changing therapeutic landscape. N Engl J Med. 2006;355:1643–1645
  18. Vevon PA, Ellison EC, Carey LC. Splenectomy for hematologic disease. Adv Surg. 1989;22:105–139
  19. Seymour JF, Cusack JD, Lerner SA, Pollock RE, Keating MJ. Case/control study of the role of splenectomy in chronic lymphocytic leukemia. J Clin Oncol. 1997;15:52–60
  20. Bouvet M, Babiera GV, Termuhlen PM, Hester JP, Kantarjian HM, Pollock RE. Splenectomy in the accelerated or blastic phase of chronic myelogenous leukemia: a single-institution, 25-year experience. Surgery. 1997;122:20–25
  21. Berman RS, Feig BW, Hunt KK, Mansfield PF, Pollock RE. Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy. Ann Surg. 2004;240:852–857
  22. Burks EJ, Loughran TP. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev. 2006;20:245–266
  23. Rashba EJ, Rowe JM, Packman CH. Treatment of the neutropenia of Felty syndrome. Blood Rev. 1996;10:177–184
  24. Berliner N, Duby AD, Linch DC, et al. T cell receptor gene rearrangements define a monoclonal T cell proliferation in patients with T cell lymphocytosis and cytopenia. Blood. 1986;67:914–918
  25. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood. 2004;104:328–335
  26. Wlodarski MW, O'Keefe C, Howe EC, et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood. 2005;106:2769–2780
  27. Nearman ZP, Wlodarski M, Jankowska AM, et al. Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias. Br J Haematol. 2007;136:237–248
  28. Viny Ad Lichtin A, Pohlman B, Loughran TP, Maciejewski JP. Chronic B-cell dyscrasias are an important clinical feature of LGL leukemia. Leuk Lymphoma. 2008;49:932–938
  29. Sokol L, Loughran TP. Large granular lymphocyte leukemia. Oncologist. 2006;11:263–273
  30. Osuji N, Matutes E, Tjonnfjord G, et al. T-cell large granular lymphocyte leukemia: a report on the treatment of 29 patients and a review of the literature. Cancer. 2006;107:570–578
  31. Sood R, Stewart CC, Aplan PD, et al. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood. 1998;91:3372–3378
  32. Furukawa Y, Tanaka K, Hasuike T, et al. Chronic lymphocytic leukemia with peripheral T lymphocytes expressing CD 2+, CD 3+, CD 4-, CD 8-, CD 16+, and CD 56+ and lymph-node lymphocytes expressing CD 2+, CD 3-, CD 4-, CD 8-, CD 16+, CD 38+, and CD 56+. Rinsho Byori. 1991;39:557–561
  33. Gentile TC, Loughran TP. Resolution of autoimmune hemolytic anemia following splenectomy in CD3+ large granular lymphocyte leukemia. Leuk Lymphoma. 1996;23:405–408
  34. Brinkman K, van Dongen JJ, van Lom K, Groeneveld K, Misere JF, van der Heul C. Induction of clinical remission in T-large granular lymphocyte leukemia with cyclosporin A, monitored by use of immunophenotyping with Vbeta antibodies. Leukemia. 1998;12:150–154
  35. Nowakowski GS, Morice WG, Phyliky RL, Li CY, Tefferi A. Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia. Br J Haematol. 2005;128:490–492
  36. Coad JE, Matutes E, Catovsky D. Splenectomy in lymphoproliferative disorders: a report on 70 cases and review of the literature. Leuk Lymphoma. 1993;10:245–264

PII: S0301-472X(08)00176-8

doi: 10.1016/j.exphem.2008.04.005

Experimental Hematology
Volume 36, Issue 9 , Pages 1078-1083 , September 2008

Article Tools

* Image Usage & Resolution